| ¿µ¹® | peptide | ÇÑ±Û | ÆéƼµå |
|---|---|---|---|
| ¼³¸í | µÎ °³ÀÌ»óÀÇ ¾Æ¹Ì³ë»ê ºÐÀÚ »çÀÌ¿¡¼, ÇÑÂÊÀÇ ¾Æ¹Ì³ë±â¿Í ´Ù¸¥ ÂÊÀÇ Ä«¸£º¹½Ç±â°¡ ¹° ºÐÀÚ¸¦ ÀÒÀ¸¸é¼ ÃàÇÕÇÏ¿© ÀÌ·ç´Â ¾Æ¹Ìµå °áÇվƹ̳ë»êÀÇ ¼ö°¡ 2, 3, ¡¦ ÀÎ °æ¿ì, °¢°¢ µðÆéƼµå, Æ®¸®ÆéƼµå, ¡¦µîÀ¸·Î ºÎ¸£¸ç, ¿©·¯ °³ÀÇ ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÇ´Â °ÍÀ» ¿Ã¸®°íÆéƼµå, À̺¸´Ù Å« °ÍÀ» Æú¸®ÆéƼµå¶ó°í ÇÑ´Ù. Á÷¼â»óÀÇ °ÍÀÌ ¸¹Áö¸¸, ȯ»ó ±¸Á¶¸¦ °®´Â ÆéƼµåµµ ÀÖ´Ù. ÀúºÐÀÚÀÇ ÆéƼµå´Â ¹°, »ê, ¾ËÄ®¸® µûÀ§¿¡ Àß ³ì°í ¾ËÄڿÿ¡´Â ³ìÁö ¾ÊÀ¸³ª, °íºÐÀÚÀÇ ÆéƼµå´Â ¹°¿¡ Àß ³ìÁö ¾Ê°í ´Ü¹éÁú°ú ¼ºÁúÀÌ ºñ½ÁÇÏ´Ù. ³úÇϼöüȣ¸£¸ó, ºê¶óµðŰ´Ñ µî°ú °°ÀÌ »ý¸®Àû±â´ÉÀÌ ÇöÀúÇÑ °ÍÀº »ý¸®È°¼ºÆéƼµå(bioactive peptide)¶ó°í ÇÑ´Ù. |
||
| C-Peptide | Connecting Peptide |
|---|---|
| ERP | early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr... |
| VIP | vasoactive intestinal peptide; vasoinhibitory peptide; venous impedance plethysmography; ventricular... |
| OA | obstructive apnea; occipital artery; occipito-anterior; occiput anterior; octanoic acid; ocular albi... |
| ODB | opiate-directed behavior |
| EOP | Endogenous opioid peptide |
|---|---|
| C-peptide | connecting peptide |
| BaEV | Baboon endogenous virus |
| EDLF | Endogenous digitalis-like factor |
| EDLS | Endogenous digitalis-like substance |
| opiate | <pharmacology> A remedy containing or derived from opium, also any drug that induces sleep. Naturally occuring basic (alkaloid) molecules with a complex fused ring structure. Have high pharmacological activity. See: morphine. (18 Nov 1997) |
|---|---|
| opiate receptor | <pharmacology> Opiate-binding sites found throughout primary afferents and the neuraxis. (16 Dec 1997) |
| opiate receptors | Regions of the brain which have the capacity to bind morphine; some, along the aqueduct of Sylvius and in the centre median, are in areas related to pain, but others, as in the striatum, are not related. (05 Mar 2000) |
| endogenous | <biology> Developing or originating within the organisms or arising from causes within the organism. Origin: Gr. Gennan = to produce (18 Nov 1997) |
| endogenous creatinine clearance | A term distinguishing measurements based on the creatinine normally present in plasma; since no infusion is necessary, an average value may be obtained by collecting urine for a long period, e.g., 24 hours. (05 Mar 2000) |
| endogenous cycle | The portion of a parasitic life cycle occurring within the host. (05 Mar 2000) |
| endogenous depression | <psychiatry> A clinical syndrome that includes a persistent sad mood or loss of interest in activities that persists for at least 2 weeks in the absence of external precipitants. This should not be confused with a grief reaction (death of loved one). Features may include change in eating habits, insomnia, early morning wakening, lack of interest, depressed mood, fatigue and suicidal thoughts. (27 Sep 1997) |
| endogenous fibres | Nerve fibre's interconnecting subdivisions of the cerebral cortex of the same hemisphere or different segments of the spinal cord on the same side. Synonym: endogenous fibres, intrinsic fibres. (05 Mar 2000) |
| endogenous infection | Infection caused by an infectious agent already present in the body, the previous infection having been inapparent. (05 Mar 2000) |
| endogenous pyrogen | Fever producing substance released by leucocytes (and Kuppfer cells in particular) that acts on the hypothalamic thermoregulatory centre. Now known to be interleukin-1. (18 Nov 1997) |
| endogenous retrovirus | <virology> A retrovirus that has become dormant and exists as DNA copies in every cell in the body of its host and is passed down from generation to generation. (09 Oct 1997) |
| endogenous virus | <virology> A virus with the ability to integrate into the genome of its host and become dormant, so that it exists as DNA copies in every cell in the body of the host and is passed down from generation to generation. A virus that causes a persistent infection. (09 Oct 1997) |
| alpha-aminoacyl-peptide hydrolases | <enzyme> Registry number: EC 3.4.11. (12 Dec 1998) |
| anionic neutrophil activating peptide | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| antibiotics, peptide | Antibiotics whose structure contains one or more peptides, usually cyclic. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|